NCT05588609 2025-09-18Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined CancersMerus B.V.Phase 2 Terminated13 enrolled
NCT03568656 2025-08-08Study to Evaluate CCS1477 in Advanced TumoursCellCentric Ltd.Phase 1/2 Completed220 enrolled